RISHI ARORA, MD
Osteopathic Medicine at Saint Clair St, Chicago, IL

License number

Illinois 036109676

Personal information

See more information about RISHI ARORA at radaris.com

Name

Address

Phone

Rishi O Arora, age 48

2800 Pine Grove Ave, Chicago, IL 60657

(773) 477-5956

Rishi O Arora, age 48

843 Adams St, Chicago, IL 60607

Rishi Arora

535 Michigan Ave, Chicago, IL 60611

Rishi Arora

21 Huron St, Chicago, IL 60611

(312) 587-3601

Rishi Arora, age 55

30 Huron St, Chicago, IL 60611

(312) 587-3601

Professional information

Software Engineer At Groupon

Position:

Software Engineer at Groupon, Co-founder, Architect, Programmer at Shiprack

Location:

Chicago, Illinois

Industry:

Computer Software

Work:

Groupon - Chicago, IL since Jun 2012 - Software Engineer Shiprack - Chicago, IL since Feb 2011 - Co-founder, Architect, Programmer Infinium Capital Management - Chicago, IL Nov 2008 - Mar 2012 - Software Engineer, Stock Options Trading Desk Motorola Solutions - Arlington Heights, IL Aug 2005 - Nov 2008 - Lead Software Architect Motorola Solutions - Schaumburg, IL Jul 1998 - Aug 2005 - Senior Software Engineer, Public Safety Networks

Education:

The University of Chicago - Booth School of Business 2007 - 2010
Master of Business Administration (MBA), Entrepreneurship, Analytic Finance Illinois Institute of Technology 2000 - 2004
Master of Science (M.S.), Computer Science Illinois Institute of Technology 1995 - 1998
Bachelor of Science (B.S.), Computer Engineering

Assistant Professor Of Medicine At Northwestern University

Position:

Assistant Professor of Medicine at Northwestern University

Location:

Greater Chicago Area

Industry:

Medical Practice

Work:

Northwestern University - Assistant Professor of Medicine Northwestern University, Feinberg School of Medicine 2011 - 2013 - Associate Professor of Medicine

Dr. Rishi Arora, Chicago IL - MD (Doctor of Medicine)

Specialties:

Cardiology, Clinical Cardiac Electrophysiology

Address:

Bloom Cardiovascular Institute
675 N Saint Clair St SUITE 100, Chicago 60611
(312) 695-4965 (Phone)
Bluhm Cardiovascular Institute
675 N Saint Clair St SUITE 19, Chicago 60611
(312) 695-2714 (Phone)

Certifications:

Cardiovascular Disease, 2000, Clinical Cardiac Electrophysiology, 2003, Internal Medicine, 1997

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

Bloom Cardiovascular Institute
675 N Saint Clair St SUITE 100, Chicago 60611
Bluhm Cardiovascular Institute
675 N Saint Clair St SUITE 19, Chicago 60611
Northwestern Memorial Hospital
251 East Huron St, Chicago 60611
Lake Forest Hospital
660 North Westmoreland Rd, Lake Forest 60045

Education:

Medical School
Lady Hardinge Medical College, University Of Delhi
Graduated: 1991
A Einstein College M Yeshiva University
Ny Hospital Med Center Of Queens

Methods For Treating Atrial Or Ventricular Arrhythmias By Administering A G-Protein Alpha Inhibitor

US Patent:

8518884, Aug 27, 2013

Filed:

May 21, 2012

Appl. No.:

13/476412

Inventors:

Rishi Arora - Chicago IL, US
Gary L. Aistrup - Chicago IL, US

Assignee:

Northwestern University - Evanston IL

International Classification:

A61K 38/00, A61P 9/12, C07K 14/575, A61K 48/00

US Classification:

514 161, 514 44 R

Abstract:

The present invention provides compositions and methods for treating heart conditions. In particular, the present invention provides compositions and methods that block G protein coupled receptor mediated signaling for treating atrial fibrillation.

Rishi Arora, Chicago IL

Specialties:

Cardiologist

Address:

675 N Saint Clair St, Chicago, IL 60611

Education:

Doctor of Medicine

Board certifications:

American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Clinical Cardiac Electrophysiology (Internal Medicine)

Compositions And Methods For Treating Or Preventing Atrial Fibrillation

US Patent:

2011028, Nov 17, 2011

Filed:

May 12, 2011

Appl. No.:

13/106618

Inventors:

Rishi Arora - Chicago IL, US
David E. Zembower - La Grange IL, US

International Classification:

A61K 31/551, A61K 31/135, A61K 31/404, A61K 31/22, A61K 31/5377, A61K 31/18, A61K 31/24, A61K 31/16, A61K 31/165, A61K 31/352, A61K 31/437, A61K 31/44, A61K 31/522, A61K 31/215, A61K 31/445, A61K 31/4725, A61K 31/4025, A61K 31/4545, A61P 9/06, A61K 31/47

US Classification:

514220, 514312, 514651, 514415, 514546, 514652, 5142362, 514605, 514538, 514629, 514620, 514456, 514603, 5142315, 514309, 514304, 514291, 514357, 51426334, 514529, 514534, 514530, 514317, 514307, 514422, 514316, 514318

Abstract:

The present invention provides compositions and methods for treating or preventing atrial fibrillation (AF). In particular, the present invention provides administration of muscarinic receptor antagonists (e.g., M2-selective muscarinic receptor blockers), administered alone or in combination with other therapeutic agents (e.g., beta-adrenergic receptor blockers) to treat and/or prevent atrial fibrillation.

Inhibition Of Fibrosis And Af By Tgf-Beta Inhibition In The Posterior Left Atrium (Pla)

US Patent:

2014003, Feb 6, 2014

Filed:

May 8, 2013

Appl. No.:

13/890116

Inventors:

Northwestern University - , US
Rishi Arora - Chicago IL, US

Assignee:

Northwestern University - Evanston IL

International Classification:

A61K 48/00, A61K 49/00

US Classification:

424 91, 514 44 R

Abstract:

The disclosed methods pertain to diagnosing whether a non-ablative, gene therapy is needed for reducing AF fibrosis in a subject, and if so, methods of reducing AF fibrosis in a subject using gene therapy with a dominant negative TGF-β R2 cDNA expression vector. Kits and computer program products are also described, wherein the kits provide materials for diagnosing and treating AF fibrosis, and the computer program products include a computer readable medium having computer readable program code for monitoring the efficacy of therapeutic ablation of fibrosis in a subject using a gene therapy method.

Devices For Material Delivery, Electroporation, Sonoporation, And/Or Monitoring Electrophysiological Activity

US Patent:

2011024, Oct 6, 2011

Filed:

Apr 6, 2011

Appl. No.:

13/080755

Inventors:

Rishi Arora - Chicago IL, US
Alan Kadish - Teaneck NJ, US
Jason Ng - Evanston IL, US

International Classification:

A61M 37/00

US Classification:

604 20, 604 22

Abstract:

The invention relates generally to systems and devices for material delivery, energy delivery, and/or monitoring electrophysiological activity, and method of use thereof. In particular, the present invention provides devices and systems, and methods of use thereof, configured to deliver therapeutic compositions, to provide electroporation and/or sonoporation to increase therapeutic efficiency, and to monitor electrophysiological activity, for example, before and after treatment.

Devices For Material Delivery, Electroporation, And Monitoring Electrophysiological Activity

US Patent:

2011013, Jun 9, 2011

Filed:

Dec 3, 2010

Appl. No.:

12/959864

Inventors:

Rishi Arora - Chicago IL, US
Alan Kadish - Bergenfield NJ, US
Jason Ng - Evanston IL, US

Assignee:

NORTHWESTERN UNIVERSITY - Evanston IL

International Classification:

A61N 1/30

US Classification:

604501, 604 21

Abstract:

The invention relates generally to devices for material delivery, electroporation and monitoring electrophysiological activity. In particular, the present invention provides devices and systems configured to deliver therapeutic compositions, to provide electroporation to increase therapeutic efficiency, and to monitor electrophysiological activity, for example, before and after treatment.